CYP3A4 immunoreactivity proved to be significantly lower in tumor tissues than in a benign epithelium; diminished immunoreactivity of CYP3A4 correlated with a poor prognosis of the disease [345]. The gene discussed is CYP3A4; the disease is neoplasm.